EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lactylation Modification in Cardiometabolic Disorders: Function and Mechanism

Xu Li, Pingdong Cai, Xinyuan Tang, Yingzi Wu, Yue Zhang, Xianglu Rong

Metabolites · 12.04.2024 · 14 (4) · 217

DOI: 10.3390/metabo14040217 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 12.04.2024. Verfasst von Xu Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou 510006, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, Guangdong Science and Technology Department, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease (CVD) is recognized as the primary cause of mortality and morbidity on a global scale, and developing a clear treatment is an important tool for improving it. Cardiometabolic disorder (CMD) is a syndrome resulting from the combination of cardiovascular, endocrine, pro-thrombotic, and inflammatory health hazards. Due to their complex pathological mechanisms, there is a lack of effective diagnostic and treatment methods for cardiac metabolic disorders. Lactylation is a type of post-translational modification (PTM) that plays a regulatory role in various cellular physiological processes by inducing changes in the spatial conformation of proteins. Numerous studies have reported that lactylation modification plays a crucial role in post-translational modifications and is closely related to cardiac metabolic diseases. This article discusses the molecular biology of lactylation modifications and outlines the roles and mechanisms of lactylation modifications in cardiometabolic disorders, offering valuable insights for the diagnosis and treatment of such conditions.

Schlagwörter

Stichwörter der Autor:innen

atherosclerosiscardiometabolic disordersdiabetesheart failurehypertensionlactylationobesity

Autor:innen und Institutionen

  • Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou 510006, China.
  • Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, Guangzhou 510006, China.
  • Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine, Guangzhou 510006, China.
  • Key Unit of Modulating Liver to Treat Hyperlipemia SATCM, State Administration of Traditional Chinese Medicine, Guangzhou 510006, China.
  • Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • Guangdong Science and Technology Department
  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Fund of Guangdong Province

Zitieren

APA

Li, X., Cai, P., Tang, X., Wu, Y., Zhang, Y., & Rong, X. (2024). Lactylation Modification in Cardiometabolic Disorders: Function and Mechanism. Metabolites, 14(4), 217. https://doi.org/10.3390/metabo14040217

Vancouver

Li X, Cai P, Tang X, Wu Y, Zhang Y, Rong X. Lactylation Modification in Cardiometabolic Disorders: Function and Mechanism. Metabolites. 2024;14(4):217. doi:10.3390/metabo14040217

BibTeX
@article{Li2024,
  author = {Li, Xu and Cai, Pingdong and Tang, Xinyuan and Wu, Yingzi and Zhang, Yue and Rong, Xianglu},
  title = {Lactylation Modification in Cardiometabolic Disorders: Function and Mechanism},
  journal = {Metabolites},
  year = {2024},
  volume = {14},
  number = {4},
  pages = {217},
  doi = {10.3390/metabo14040217}
}
Kostenlos starten →